In Vitro Combinations of Baloxavir Acid and Other Inhibitors against Seasonal Influenza A Viruses
Two antiviral classes, the neuraminidase inhibitors (NAIs) and polymerase inhibitors (baloxavir marboxil and favipiravir) can be used to prevent and treat influenza infections during seasonal epidemics and pandemics. However, prolonged treatment may lead to the emergence of drug resistance. Therapeu...
Main Authors: | Liva Checkmahomed, Blandine Padey, Andrés Pizzorno, Olivier Terrier, Manuel Rosa-Calatrava, Yacine Abed, Mariana Baz, Guy Boivin |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Viruses |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4915/12/10/1139 |
Similar Items
-
Susceptibility of Influenza A, B, C, and D Viruses to Baloxavir
by: Vasiliy P. Mishin, et al.
Published: (2019-10-01) -
Advanced researches on the inhibition of influenza virus by Favipiravir and Baloxavir
by: Qiongqiong Fang, et al.
Published: (2020-06-01) -
Treatment of Highly Pathogenic H7N9 Virus-Infected Mice with Baloxavir Marboxil
by: Maki Kiso, et al.
Published: (2019-11-01) -
Susceptibility of Influenza Viruses to the Novel Cap-Dependent Endonuclease Inhibitor Baloxavir Marboxil
by: Emi Takashita, et al.
Published: (2018-12-01) -
Human-to-Human Transmission of Influenza A(H3N2) Virus with Reduced Susceptibility to Baloxavir, Japan, February 2019
by: Emi Takashita, et al.
Published: (2019-11-01)